XML 84 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Statements of Convertible Preferred Stock, Redeemable Convertible Preferred Stock and Stockholders' Deficit (USD $)
In Thousands, except Share data, unless otherwise specified
Total
USD ($)
Common Stock
Additional Paid-In Capital Amount
USD ($)
Accumulated Other Comprehensive Income (Loss)
USD ($)
Accumulated Deficit
USD ($)
Comprehensive Income (Loss)
USD ($)
Series A-1 Convertible Preferred Stock
USD ($)
Series A-2 Convertible Preferred Stock
USD ($)
Series A-3 Convertible Preferred Stock
USD ($)
Series A-4 Convertible Preferred Stock
USD ($)
Series A-5 Convertible Preferred Stock
USD ($)
Series A Convertible Preferred Stock
USD ($)
Series B Convertible Preferred Stock
USD ($)
Series C Convertible Preferred Stock
USD ($)
Balance at Dec. 31, 2009 $ (101,598)   $ 3 $ 15 $ (101,616)             $ 93 $ 35,470 $ 96,131
Balance (in shares) at Dec. 31, 2009   320,424                   61,664 1,599,997 10,146,629
Increase (Decrease) in Stockholders' Equity                            
Net loss (14,630)       (14,630) (14,630)                
Unrealized loss from available-for-sale securities (18)     (18)   (18)                
Issuance of common stock 2   2                      
Issuance of common stock (in shares)   2,383                        
Stock-based compensation expense 134   134                      
Accretion of preferred stock issuance costs (173)   (136)   (37)                 173
Accretion of preferred stock to redemption value (10,651)       (10,651)               2,839 7,812
Accretion of preferred stock investor rights/obligations (1,318)       (1,318)                 1,318
Balance at Dec. 31, 2010 (128,252)   3 (3) (128,252)             93 38,309 105,434
Balance (in shares) at Dec. 31, 2010   322,807                   61,664 1,599,997 10,146,629
Increase (Decrease) in Stockholders' Equity                            
Net loss (42,476)       (42,476) (42,476)                
Unrealized loss from available-for-sale securities 8     8   8                
Forced conversion to common stock 554   554                 (33) (296) (225)
Forced conversion to common stock (in shares)   102,767                   (21,661) (177,697) (314,496)
Recapitalization [1] 60,981   8,269   52,712     75,979 9,629 271   (60) (39,183) (108,425)
Recapitalization (in shares) [1]               983,208 142,227 3,998   (40,003) (1,422,300) (9,832,133)
Issuance of preferred stock             62,297       525      
Issuance of preferred stock (in shares)             922,286       6,443      
Accretion of dividends on preferred stock (10,933)   (6,590)   (4,343)   1,968 4,000 579       1,170 3,216
Stock-based compensation expense 304   304                      
Stock options exercised 204   204                      
Stock options exercised (in shares)   219,825                        
Milestone payment settled with stock             1,410              
Milestone payment settled with stock (in shares)             17,326              
Balance at Dec. 31, 2011 (119,610)   2,744 5 (122,359)   65,675 79,979 10,208 271 525      
Balance (in shares) at Dec. 31, 2011   645,399         939,612 983,208 142,227 3,998 6,443      
Increase (Decrease) in Stockholders' Equity                            
Net loss (69,128)       (69,128) (69,128)                
Unrealized loss from available-for-sale securities (5)     (5)   (5)                
Accretion of dividends on preferred stock (13,992)   (4,818)   (9,174)   6,282 6,735 974          
Stock-based compensation expense 1,795   1,795                      
Stock options exercised 279   279                      
Stock options exercised (in shares)   221,805                        
Balance at Dec. 31, 2012 $ (200,661)       $ (200,661)   $ 71,957 $ 86,714 $ 11,182 $ 271 $ 525      
Balance (in shares) at Dec. 31, 2012   867,204         939,612 983,208 142,227 3,998 6,443      
[1] The recapitalization includes the exchange of Series A, Series B and Series C shares for Series A-4, Series A-3, and Series A-2 shares, respectively, in addition to the 1:10 exchange of Series A-2, Series A-3, and Series A-4 preferred stock, which occurred in conjunction with the Merger, and is more fully described in note 4.